Search PubMed⌕ Search

PubMed · 1849449

Pulmonary blastomas.

Abstract

Pulmonary blastoma is a rare lung tumor composed of immature mesenchyme and/or epithelium that morphologically mimics embryonal pulmonary structure. The prognosis of these tumors is poor, and the clinical course is not readily predicted from histologic appearance. In this report, the clinical, gross, microscopic, and immunopathologic features of 52 cases are described, and prognostically important correlates are determined. Twenty-eight patients were women, and 24 were men. There was a unimodal age peak in the fourth decade; only two patients were younger than 10 years old, and both had biphasic blastomas. Forty-one percent of patients were asymptomatic. Chest radiography typically showed a peripheral or midlung mass without predilection for any lobe. Microscopically, tumors could be divided into two classes: those composed solely of malignant glands of embryonal appearance (well-differentiated fetal adenocarcinomas [WDFA], 28 cases) and those with a biphasic appearance (24 cases). The malignant epithelium contained cytokeratin, carcinoembryonic antigen, milk fat globulin, and often chromogranin; vimentin, actin, and less frequently desmin and myoglobin were present in malignant stromal cells. More often WDFA was a smaller tumor (less than 5 cm) than biphasic tumors (P less than or equal to 0.001). It was more likely to be asymptomatic (P less than or equal to 0.001), and it was less likely to show pleural effusion by chest radiography (P less than or equal to 0.01) or giant or bizarre tumor cells (P less than or equal to 0.001) or frequent (greater than or equal to 30 mitoses/10 high-power fields) mitoses in the microscopic sections (P less than or equal to 0.01). Only 14% of patients with WDFA died of their tumor; 52% of patients with biphasic tumors died (mean follow-up, 97 months and 49 months, respectively). For patients with WDFA, the presence of thoracic adenopathy by chest radiography (P less than or equal to 0.001) and metastasis at initial presentation (P less than or equal to 0.001), followed by tumor recurrence (P less than or equal to 0.01), were the factors most highly correlated with poor prognosis. For patients with biphasic tumors, tumor recurrence (P less than or equal to 0.001) was the most significant indicator of poor prognosis, followed by metastasis at initial presentation (P less than or equal to 0.05) and gross size of the tumor (greater than or equal to 5 cm) (P less than or equal to 0.05). These findings support the idea that histologic class and gross and clinical findings can be of prognostic value in pulmonary blastoma.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M N Koss, L Hochholzer, T O'Leary. 1991-05-01. Pulmonary blastomas.. https://doi.org/10.1002/1097-0142(19910501)67%3A9%3C2368%3A%3Aaid-cncr2820670926%3E3.0.co%3B2-g

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Survival of patients with untreated rectal cancer.

BACKGROUND AND OBJECTIVES: Untreated rectal cancer is uncommon given modern surgical techniques and chemoradiotherapy. However, neglected cancer may still occur in patients with limited access to medical care or who refuse conventional interventions. Outcome data on such patients is scarce, though valuable in educating patients on their prognosis or to compare with present therapeutic options. METHODS: To identify such data, a review was made of archival literature documenting outcomes in patients with untreated rectal cancer. A review of the Index Medicus and its predecessor volumes and an extensive MEDLINE search led to nine articles that contained relevant age at presentation data of patients with rectal cancer. Six articles also included patient survival data for untreated rectal cancer. Actuarial analysis of the data through 5 years post-diagnosis was completed. RESULTS: Symptoms most often presented in the fifth and sixth decades. Median survival of the 1326 patients fell within the second year after presentation of symptoms. Five-year actuarial survival for these patients was 4.4%. When the data published prior to 1925 were analyzed separately from that published post-1925, two survival patterns emerged. Median survival of pre-1925 patients fell within the second year after presentation of symptoms (at 21.5 months by curve fitting) and of post-1925 patients fell within the first year (10.2 months). CONCLUSIONS: Clearly, advances in antibiotics, surgery, chemoradiotherapy, and supportive care have contributed to increased survival for patients with treated rectal cancer. Recognizing the hazards of generalizing too extremely from the data, they reveal that relatively long survival for patients with untreated lesions is possible.

Actuarial Analysis↗

Dual-kidney transplantation with organs from expanded criteria donors: a long-term follow-up.

BACKGROUND: Since 1995, dual-kidney transplantation using organs from marginal donors has been used at our center to expand the organ donor pool and decrease the waiting time for deceased donor kidney transplantation. This approach has allowed for a shorter waiting period without compromising outcome in the early posttransplant period. We now have 8-year follow-up in the first recipients. Older individuals were offered this option preferentially, because we reasoned that they would stand to benefit most from the shorter waiting period. METHODS: Patients aged 55 years or more who underwent either dual-kidney transplantation with expanded criteria donors or single-kidney transplantation with standard donors were included in this study. All expanded criteria donor organs were those that were refused by all other local transplant centers. The primary endpoints were recipient death and graft failure. RESULTS: Waiting time for dual-kidney transplantation was 440 +/- 38 days versus 664 +/- 51 days for single-kidney transplantation (P<0.01). The 8-year actuarial patient survivals for the single- and dual-kidney transplants were 74.1% and 82.1%, respectively. The 8-year actuarial graft survivals for the single- and dual-kidney transplants were 59.4% and 69.7%, respectively. CONCLUSIONS: Eight-year actuarial patient and graft survivals in older individuals who underwent dual-kidney transplantation are equivalent to those who underwent standard single-kidney transplantation. With the continuing organ shortage and increasing waiting times for cadaver kidney transplantation, dual-kidney transplantation using organs that would otherwise be discarded offers a good option for older individuals who may not withstand a long waiting period.

Actuarial Analysis↗